Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 ORAL MELPHALAN THERAPY IN ADVANCED MALIGNANT DISEASE.

Literature DB >> 14065057

ORAL MELPHALAN THERAPY IN ADVANCED MALIGNANT DISEASE.

Abstract

Keywords: ADOLESCENCE; CHILD; GERIATRICS; HODGKIN'S DISEASE; LEUKEMIA, LYMPHOCYTIC; LYMPHOSARCOMA; MANDIBULAR NEOPLASMS; MAXILLARY NEOPLASMS; MELANOMA; MELPHALAN; MULTIPLE MYELOMA; NECK NEOPLASMS; NEOPLASM THERAPY; ORBITAL NEOPLASMS; PLASMACYTOMA; SARCOMA, KAPOSI'S; SARCOMA, RETICULUM CELL

Mesh：

Substances：
Melphalan

Year: 1963 PMID： 14065057 PMCID： PMC2071042 DOI： 10.1038/bjc.1963.53

Source DB: PubMed Journal: Br J Cancer ISSN： 0007-0920 Impact factor: 7.640

× No keyword cloud information.

5 in total

1. Nitrogen mustard therapy with aortic occlusion in nasopharyngeal carcinoma.

Authors: P CLIFFORD; H G OETTGEN; J L BEECHER; F P BROWN; J R HARRIES; W E LAWES
Journal: Br Med J Date: 1963-05-11

2. Malignant disease of the nose, paranasal sinuses and post-nasal space in East Africa.

Authors: P CLIFFORD
Journal: J Laryngol Otol Date: 1961-08 Impact factor: 1.469

3. Studies of phenylalanine nitrogen mustard (CB 3025) in metastatic malignant melanoma of man.

Authors: J F HOLLAND; W REGELSON
Journal: Ann N Y Acad Sci Date: 1958-04-24 Impact factor: 5.691

4. Action of p-[di(2-chloroethyl)]-amino-l-phenylalanine on Harding-Passey mouse melanoma.

Authors: J M LUCK
Journal: Science Date: 1956-06-01 Impact factor: 47.728

5. Preliminary clinical trial of p-di-2-chloroethyl-amino-L-phenylalanine (CB 3025, melphalan) and of di-2-chloroethyl methanesulfonate (CB 1506).

Authors: R PAPAC; D A GALTON; M TILL; E WILTSHAW
Journal: Ann N Y Acad Sci Date: 1958-04-24 Impact factor: 5.691

5 in total

3 in total

ORAL MELPHALAN THERAPY IN ADVANCED MALIGNANT DISEASE.

1. Nitrogen mustard therapy with aortic occlusion in nasopharyngeal carcinoma.

2. Malignant disease of the nose, paranasal sinuses and post-nasal space in East Africa.

3. Studies of phenylalanine nitrogen mustard (CB 3025) in metastatic malignant melanoma of man.

4. Action of p-[di(2-chloroethyl)]-amino-l-phenylalanine on Harding-Passey mouse melanoma.

5. Preliminary clinical trial of p-di-2-chloroethyl-amino-L-phenylalanine (CB 3025, melphalan) and of di-2-chloroethyl methanesulfonate (CB 1506).

1. Proteometabolomics of Melphalan Resistance in Multiple Myeloma.

2. The effects of some cancer chemotherapy agents on the sulphydryl levels of normal rat tissues.

3. Paradoxes of hematology: When the old disappears and the new does not arrive.